{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:34:20Z","timestamp":1771054460090,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KG0923"],"award-info":[{"award-number":["01KG0923"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.jad.2012.06.007","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T16:15:13Z","timestamp":1347034513000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"144","author":[{"given":"A.","family":"von Wolff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"H\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"H\u00e4rter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kriston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2012.06.007_bib1","first-page":"73","article-title":"Role of selective serotonin reuptake inhibitors on the treatment of chronic and\/or resistant major depression","volume":"17","author":"Aguglia","year":"1995","journal-title":"Giornale Di Neuropsicofarmacologia"},{"key":"10.1016\/j.jad.2012.06.007_bib2","series-title":"Practice Guideline for the Treatment of Patients with Major Depressive Disorder","author":"American Psychiatric Association","year":"2010"},{"key":"10.1016\/j.jad.2012.06.007_bib3","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0006-3223(99)00211-5","article-title":"Interleukin-1 beta production in dysthymia before and after pharmacotherapy","volume":"46","author":"Anisman","year":"1999","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0278-5846(03)00038-1","article-title":"Sertraline is more effective than imipramine in the treatment of non-melancholic depression: Results from a multicentre, randomized study","volume":"27","author":"Baca","year":"2003","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004714-199312000-00006","article-title":"Ritanserin, imipramine and placebo in the treatment of dysthymic disorder","volume":"13","author":"Bakish","year":"1993","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.06.007_bib6","first-page":"405","article-title":"Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years","volume":"50","author":"Barrett","year":"2001","journal-title":"Journal of Family Practice"},{"key":"10.1016\/j.jad.2012.06.007_bib7","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1176\/appi.ajp.157.6.940","article-title":"Lost human capital from early-onset chronic depression","volume":"157","author":"Berndt","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib8","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/0924-9338(96)85188-1","article-title":"Atypical antipsychotic drugs in dysthymia: placebo controlled studies of amisulpride versus imipramine, versus amineptine","volume":"11","author":"Boyer","year":"1996","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1016\/j.jad.2012.06.007_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00019442-200501000-00009","article-title":"Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder","volume":"13","author":"Devanand","year":"2005","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib11","series-title":"Meta-Analysis in Context","article-title":"Systematic reviews in health care","author":"Egger","year":"2003"},{"key":"10.1016\/j.jad.2012.06.007_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0447.2005.00633.x","article-title":"Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project","volume":"112","author":"Gilmer","year":"2005","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2012.06.007_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/YIC.0b013e328333c35e","article-title":"Ecitalopram versus placebo in the treatment of dysthymic disorder","volume":"25","author":"Hellerstein","year":"2010","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.06.007_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0278-5846(94)90030-2","article-title":"Lomg-term treatment of double depression - a preliminary-study with serotonergic antidepressants","volume":"18","author":"Hellerstein","year":"1994","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib15","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1176\/ajp.150.8.1169","article-title":"A randomized double-blind study of fluoxetine versus placebo in the treatment of Dysthymia","volume":"150","author":"Hellerstein","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib16","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., Green, S. (Eds.), 2009. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration.","DOI":"10.1002\/9780470712184"},{"key":"10.1016\/j.jad.2012.06.007_bib17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ\u2014British Medical Journal"},{"key":"10.1016\/j.jad.2012.06.007_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4088\/JCP.v59n1107","article-title":"The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine","volume":"59","author":"Keller","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib19","unstructured":"Khan, K.S., Ter Riet, G., Glanville, J., Sowden, A.J., Kleijnen, J., 2001. Undertaking Systematic Reviews of Research on Effectiveness, CRD's Guidance for those Carrying Out or Commissioning Reviews. CRD Report Number 4, 2nd Edition. NHS Centre for Reviews and Dissemination, University of York, Heslington, York."},{"key":"10.1016\/j.jad.2012.06.007_bib20","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jad.2012.06.007_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0963721410366007","article-title":"Chronic depression: diagnosis and classification","volume":"19","author":"Klein","year":"2010","journal-title":"Current Directions in Psychological Science"},{"key":"10.1016\/j.jad.2012.06.007_bib22","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.145.8.997","article-title":"Imipramine and social-vocational adjustment in chronic depression","volume":"145","author":"Kocsis","year":"1988","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2012.06.007_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-244X-10-95","article-title":"Effectiveness of psychotherapeutic, pharmacological, and combined treatments for chronic depression: a systematic review (METACHRON)","volume":"23","author":"Kriston","year":"2010","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib24","doi-asserted-by":"crossref","unstructured":"Lima, M.S., Moncrieff, J., Soares, B.G.O., 2005. Drugs versus placebo for dysthymia. Cochrane Database System Review, art. no.: CD001130. http:\/\/doi:10.1002\/14651858.CD001130.","DOI":"10.1002\/14651858.CD001130"},{"key":"10.1016\/j.jad.2012.06.007_bib25","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jad.2012.06.007_bib26","unstructured":"National Institute for Health and Clinical Excellence (NICE), 2009. Depression: The Treatment and Management of Depression in Adults. National Clinical Practice Guideline 90. National Institute for Health and Clinical Excellence (NICE), London."},{"key":"10.1016\/j.jad.2012.06.007_bib27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1176\/ajp.156.10.1608","article-title":"Treatment of primary dysthymia with group cognitive therapy and pharmacotherapy: clinical symptoms and functional impairments","volume":"156","author":"Ravindran","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4088\/JCP.v61n1103","article-title":"Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression","volume":"61","author":"Ravindran","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0278-5846(92)90111-Q","article-title":"A preliminary study of serotonergic antidepressants in treatment of Dysthymia","volume":"16","author":"Rosenthal","year":"1992","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4088\/JCP.v59n1106","article-title":"The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies","volume":"59","author":"Rush","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/070674370905400606","article-title":"Prevalence and correlates of chronic depression in the Canadian Community Health Survey: Mental health and well-being","volume":"54","author":"Satyanarayana","year":"2009","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jad.2005.11.014","article-title":"Effectiveness and cost-effectiveness of antidepressant treatment in primary health care: a six-month randomised study comparing Fluoxetine to Imipramine","volume":"91","author":"Serrano-Blanco","year":"2006","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2012.06.007_bib32","series-title":"Systematic reviews in health care: meta-analysis in context","first-page":"248","article-title":"Investigating and dealing with publication and other biases","author":"Sterne","year":"2003"},{"key":"10.1016\/j.jad.2012.06.007_bib33","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archpsyc.1985.01790350022005","article-title":"Treatment outcome validation of DSM-III depressive subtypes: clinical usefulness in outpatients with mild to moderate depression","volume":"42","author":"Stewart","year":"1985","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpsyc.1996.01830090023004","article-title":"A placebo-controlled, randomized clinical trial comparing Sertraline and Imipramine for the treatment of dysthymia","volume":"53","author":"Thase","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11920-008-0074-6","article-title":"Chronic depression: update on classification and treatment","volume":"10","author":"Torpey","year":"2008","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.jad.2012.06.007_bib36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jad.2012.06.007_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(88)92535-4","article-title":"The Nottingham study of neurotic disorder: comparison of drug and psychological treatments","volume":"2","author":"Tyrer","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2012.06.007_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1192\/bjp.170.4.345","article-title":"Controlled efficacy study of Fluoxetine in dysthymia","volume":"170","author":"Vanelle","year":"1997","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2012.06.007_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00004850-199707000-00001","article-title":"Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial","volume":"12","author":"Versiani","year":"1997","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2012.06.007_bib40","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.284.12.1519","article-title":"Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults","volume":"284","author":"Williams","year":"2000","journal-title":"Jama\u2014Journal of the American Medical Association"},{"key":"10.1016\/j.jad.2012.06.007_bib41","unstructured":"Wilson, D.B., 2010. SPSS, Stata, and SAS macros for performing meta-analytic analyses. \u3008http:\/\/mason.gmu.edu\/\u223cdwilsonb\/ma.html\u3009, (accessed 31.10.11)."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271200451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503271200451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:11:16Z","timestamp":1759021876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503271200451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":42,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S016503271200451X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2012.06.007","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2012.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}